Literature DB >> 2697481

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I.

D S Kiddy1, D Hamilton-Fairley, M Seppälä, R Koistinen, V H James, M J Reed, S Franks.   

Abstract

The purpose of this study was to investigate the effect of calorie restriction on serum concentrations of sex hormone binding globulin (SHBG) in women with normal or polycystic ovaries (PCO) and to examine the possible role of insulin and insulin-like growth factor-I (IGF-I) in mediating changes in SHBG levels. Six normal subjects with mean (SD) body mass index (BMI) 25.5 (2.2) and five subjects with PCO (BMI 36.1 (3.7)) were studied before and after 2 or (PCO only) 4 weeks of a very low calorie diet (330 kcal/day; Cambridge Diet). In both normal women and patients with PCO there was a twofold increase in SHBG concentrations after 2 weeks and this was sustained in the PCO subjects for a further 2 weeks. The rise in SHBG was accompanied by a fall in free testosterone concentrations. There were parallel changes in serum insulin and IGF-I concentrations which decreased during the diet and there were significant negative correlations of SHBG with insulin in both normal subjects (r = -0.62) and women with PCO (r = -0.60). In addition, serum concentrations of an insulin-dependent small molecular weight (34 kDa) binding protein for IGF-I (IGF-BPI) increased significantly during dieting in both groups and were negatively correlated with serum insulin (controls, r = -0.56; PCO, r = -0.68) and positively correlated with serum SHBG levels (controls, r = 0.69; PCO, r = 0.63). In summary, these data indicate that in both normal subjects and those subjects with PCO, calorie restriction results in a highly significant increase in SHBG concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697481     DOI: 10.1111/j.1365-2265.1989.tb01297.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  19 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

2.  Hirsutism.

Authors:  G S Conway; H S Jacobs
Journal:  BMJ       Date:  1990-09-29

Review 3.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

Review 4.  ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated?

Authors:  J H Barth
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

5.  Effects of abstinence on sex hormone profile in alcoholic patients without liver failure.

Authors:  H Iturriaga; L Valladares; S Hirsch; E Devoto; C P'erez; D Bunout; X Lioi; M Petermann
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

Review 6.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

Review 7.  How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

Authors:  C Cortet-Rudelli; D Dewailly
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

8.  Maternal whole grain intake and outcomes of in vitro fertilization.

Authors:  Audrey J Gaskins; Yu-Han Chiu; Paige L Williams; Myra G Keller; Thomas L Toth; Russ Hauser; Jorge E Chavarro
Journal:  Fertil Steril       Date:  2016-02-28       Impact factor: 7.329

Review 9.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

10.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.